Thrombotic Thrombocytopenic Purpura after Percutaneous Coronary Intervention.
10.3904/kjim.2006.21.2.120
- Author:
Jung Min LEE
1
;
Seung Ho HUR
;
Chang Wook NAM
;
Seung Wook HAN
;
Kee Sik KIM
;
Yoon Nyun KIM
;
Kwon Bae KIM
Author Information
1. Division of Cardiology, College of Medicine, Keimyung University, Dongsan Medical Center, Daegu, Korea. ncwcv@dsmc.or.kr
- Publication Type:Case Report
- Keywords:
Thrombotic thrombocytopenic purpura;
Percutaneous coronary intervention;
Hepatitis;
Pancreatitis
- MeSH:
Stents/*adverse effects;
Purpura, Thrombotic Thrombocytopenic/diagnosis/*etiology;
Humans;
Female;
Angioplasty, Transluminal, Percutaneous Coronary/*adverse effects;
Aged
- From:The Korean Journal of Internal Medicine
2006;21(2):120-122
- CountryRepublic of Korea
- Language:English
-
Abstract:
Thrombotic thrombocytopenic purpura (TTP) is a rapidly progressive hematological syndrome defined by the pentad of thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, fever and renal dysfunction. TTP has been associated with major surgical procedures and specific medications. However, there is no known previously reported case in which acute TTP occurred after a percutaneous coronary intervention (PCI). We report a case of TTP after a PCI, that presented with the pentad of symptoms, as well as hepatitis and pancreatitis.
